Who is sponsoring NCT05348850?

NCT05348850 is sponsored by Cairo University.

What drugs are being tested in NCT05348850?

Interventions in NCT05348850: Tensiomayography (TMG).

What condition does NCT05348850 study?

NCT05348850 studies Patellofemoral Pain Syndrome.

Is NCT05348850 still recruiting?

NCT05348850 is currently completed. Last updated 17 January 2023.

Last reviewed 2023-01-17 · How we verify

NCT05348850

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quadriceps Muscle Contractile Properties and Functional Performance

Completed Last updated 17 January 2023

What this trial tests

trial testing Tensiomayography (TMG) in Patellofemoral Pain Syndrome in 30 participants. Completed in 1 January 2023.

Timeline

20 April 2022

Primary endpoint
20 September 2022

1 January 2023

Quick facts

Lead sponsor	Cairo University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	20 April 2022
Primary completion	20 September 2022
Estimated completion	1 January 2023
Sites	1 location across Egypt

Drugs / interventions tested

Tensiomayography (TMG)

Conditions studied

Patellofemoral Pain Syndrome — all drugs for Patellofemoral Pain Syndrome →

Sponsor

Cairo University

Who can join

Adults 18 to 30, any sex, with Patellofemoral Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the association between tensiomyography parameters (from rectus femoris, vastus lateralis and vastus medialis) and functional abilities in runners with patellofemoral pain syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Patellofemoral Pain Syndrome

Currently open trials in the same condition.

NCT07318987 — EFFECT OF SAPHENOUS NERVE RELEASE ON PATIENTS WITH PATELLOFEMORAL PAIN SYNDROME · NA · recruiting
NCT06913426 — Effects of Pelvic Tilt Exercises Along With Hip and Knee Focused Exercises on Patients With Patellofemoral Pain Syndrome · NA · active not recruiting
NCT06875804 — Compressive Myofascial Release of the Vastus Lateralis on Lateral Patellar Tracking in Patellofemoral Pain Syndrome · NA · recruiting
NCT06598618 — Comparison of IASTM and Muscle Energy Technique in Patellofemoral Pain Syndrome. · NA · recruiting
NCT06566950 — BFR Training on Muscle Morphology · NA · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05348850 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 17 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05348850.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing